Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Endogeneous nucleic acid fragment associated with an autoimmune disease, labeling method and reagent

Endogeneous nucleic acid fragment associated with an autoimmune disease, labeling method and reagent

US Patent 7632931 · Granted Dec 15, 2009

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Method for determining in vitro or ex vivo the immune status of an individual2024
Method for the diagnosis or prognosis, in vitro, of lung cancer2022
Method for the diagnosis or prognosis, in vitro, of testicular cancer2022
Method for the diagnosis or prognosis, in vitro, of prostate cancer2022
Method for in vitro diagnosis or prognosis of colon cancer2022
Method for the in vitro diagnosis or prognosis of ovarian cancer2022
Hydrazone derivatives for preventing or treating EBV-related cancers2022
Method for in vitro diagnosis or prognosis of testicular cancer2021
Method for estimating the probe-target affinity of a DNA chip and method for man2021
Bioresorbable nonlamellar microparticles and uses thereof2019
Method for in vitro diagnosis or prognosis of testicular cancer2019
Methods for producing peptides including HERV-W envelope motifs and for producin2018